Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering receptors activated solely by synthetic ligands (RASSLs).

K Scearce-Levie1, P Coward, C H Redfern

  • 1Gladstone Institute of Cardiovascular Disease, Gladstone Institute of Neurological Disease, Depts of Medicine and Pharmacology, University of California, San Francisco, PO Box 419100, San Francisco, CA 94141-9100, USA.

Trends in Pharmacological Sciences
|August 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validated assays for the quantification of C9orf72 human pathology.

Scientific reports·2024
Same author

Prospective Design of Anti-Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain.

CPT: pharmacometrics & systems pharmacology·2016
Same author

Fracture of a ceramic component in total hip replacement.

The Journal of bone and joint surgery. British volume·2012
Same author

Mineral composition is altered by osteoblast expression of an engineered G(s)-coupled receptor.

Calcified tissue international·2011
Same author

Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia.

Endocrinology·2007
Same author

Abnormal social behaviors in mice lacking Fgf17.

Genes, brain, and behavior·2007

Receptors activated solely by synthetic ligands (RASSLs) offer precise control over G-protein signaling pathways. This technology aids in studying complex physiological and pathological responses, including cardiac function and neurobehavior.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Physiology

Background:

  • G-protein-coupled receptors (GPCRs) exhibit vast diversity, complicating the link between signaling pathways and physiological/pathological outcomes.
  • Controlling the timing and specificity of GPCR signaling is crucial for understanding cellular responses.

Purpose of the Study:

  • To introduce Receptors Activated Solely by Synthetic Ligands (RASSLs) as tools for precise G-protein signal manipulation.
  • To enable spatio-temporal control over G-protein signaling in vivo.

Main Methods:

  • Engineering GPCRs to respond exclusively to synthetic ligands (drugs) rather than endogenous peptides.
  • Utilizing RASSLs in conjunction with tissue-specific expression systems for targeted in vivo activation.

Related Experiment Videos

Main Results:

  • RASSLs provide a method to isolate and study specific G-protein signaling pathways.
  • Existing RASSLs have elucidated the role of G(i) signaling in cardiac physiology.

Conclusions:

  • RASSLs offer a powerful approach to dissect complex signaling networks.
  • This technology is instrumental in ongoing research for conditions like cardiomyopathy, muscle remodeling, and neurobehavioral studies.